Serial Number 88304150
Registration 6672523
700

Registration Progress

Application Filed
Feb 15, 2019
Under Examination
Jul 30, 2019
Approved for Publication
Jun 4, 2019
Published for Opposition
Jun 4, 2019
Registered
Mar 15, 2022

Trademark Image

Basic Information

Serial Number
88304150
Registration Number
6672523
Filing Date
February 15, 2019
Registration Date
March 15, 2022
Published for Opposition
June 4, 2019
Drawing Code
2000

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 15, 2022
Registration
Registered
Classes
042

Rights Holder

TRAVERE THERAPEUTICS, INC.

03
Address
3611 VALLEY CENTRE DRIVE
SUITE 300
SAN DIEGO, CA 92130

Ownership History

Retrophin, Inc.

Original Applicant
03
San Diego, CA

Retrophin, Inc.

Owner at Publication
03
San Diego, CA

TRAVERE THERAPEUTICS, INC.

New Owner After Publication #1
03
SAN DIEGO, CA

TRAVERE THERAPEUTICS, INC.

Original Registrant
03
SAN DIEGO, CA

Legal Representation

Attorney
Hayley J. Talbert

USPTO Deadlines

Next Deadline
967 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-03-15)
Due Date
March 15, 2028
Grace Period Ends
September 15, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

33 events
Date Code Type Description Documents
Mar 15, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 8, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Feb 7, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jan 10, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jan 7, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 15, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Dec 15, 2021 IUAF S USE AMENDMENT FILED Loading...
Jun 18, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 16, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 16, 2021 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 16, 2021 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jan 12, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 8, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 8, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Jan 8, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 23, 2020 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jul 11, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 9, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 9, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 9, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 10, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 8, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 8, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 8, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 30, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 4, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 4, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 15, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 27, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 26, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 21, 2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Mar 9, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 19, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Research and development of pharmaceuticals for the treatment of rare diseases; research and development for the treatment of hypertension, kidney stones, gallstones, cholesterol, rage disorders, lactation, schizophrenia, autism, kidney disease, neurodegeneration, infantile spasms, nephrotic syndrome, muscular dystrophy, and diabetic nephropathy
First Use Anywhere: Dec 10, 2021
First Use in Commerce: Dec 10, 2021

Additional Information

Design Mark
The mark consists of a pathway through a center of a circle, the pathway dividing individual triangles in lighter shading that becomes darker toward the center on the left side of the pathway and darker shading that becomes lighter toward the bottom on the right side of the pathway.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
042